The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer.
about
Phase I study of capecitabine combined with radioembolization using yttrium-90 resin microspheres (SIR-Spheres) in patients with advanced cancerClinical efficacy of including capecitabine in neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis of randomized controlled trials.The search for enhanced therapeutic index in breast cancer: targeting the tumor and modulation of enzyme expression.Novel pharmacological approaches in the treatment of breast cancer.Brain Metastases from Breast Cancer and Response to Treatment with Eribulin: A Case SeriesPharmacokinetics, safety, and hydrolysis of oral pyrroloquinazolinediamines administered in single and multiple doses in ratsCost of managing women presenting with stage IV breast cancer in the United Kingdom.Phase II study of capecitabine in combination with paclitaxel in patients with anthracycline-pretreated advanced/metastatic breast cancer.Comparison of the 5-fluorouracil-warfarin and capecitabine-warfarin drug interactions.Capecitabine for treating head and neck cancer.First evidence of oncologic neuropathic pain prevalence after screening 8615 cancer patients. Results of the On study.Evaluation of the clinical benefits of adjuvant capecitabine monotherapy in elderly women with breast cancer: A retrospective study.N-[2-Chloro-6-(4-chloro-6-methoxy-pyrimidin-2-ylsulfan-yl)benz-yl]-3,4-dimethyl-aniline.4-Chloro-2-{3-chloro-2-[(3,5-dimethyl-piperidin-1-yl)meth-yl]phenyl-sulfan-yl}-6-methoxy-pyrimidine.Cu(II) /TEMPO-promoted one-pot synthesis of highly substituted pyrimidines from amino acid esters.
P2860
Q33918145-32DAA612-8CD3-4962-B623-0331F2C493B1Q34542467-8F261CBD-CD42-4939-A17F-918FD60CBC72Q35004485-33A1CBAC-50A6-4ED0-A67E-1A89E196A6FEQ35143980-45CA8FA0-05AF-49A2-9EFB-8F587258AF84Q35647947-0DA6AF0B-2E0B-4F6F-A632-9B8617A523E0Q35912715-6FDB6EC0-0834-4A30-B318-78AF7FDE45BFQ36625908-75910000-1865-4024-93F4-2C9BED88EE21Q36697132-3CC23A41-76CB-46F7-9659-F06564A3F7FCQ37815492-77D91B49-FEF2-4340-A602-F9BAB8A4262AQ38825147-F04B2F49-78F2-4406-A639-B9981498F4CBQ39278779-7727DA44-4276-4802-A88C-56229B036D77Q41541955-E586B51F-B70C-495C-9A02-2718C70D99F2Q41934620-D1C6B955-9652-4B9A-8DE1-560E00A3C992Q42023035-DC72D44B-61B0-4F82-83A2-ACF1501F7732Q51036951-1BEF211A-C58F-4085-B8FC-9033EE858A80
P2860
The role of capecitabine, an oral, enzymatically activated fluoropyrimidine, in the treatment of metastatic breast cancer.
description
2001 nî lūn-bûn
@nan
2001 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2001 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2001年の論文
@ja
2001年論文
@yue
2001年論文
@zh-hant
2001年論文
@zh-hk
2001年論文
@zh-mo
2001年論文
@zh-tw
2001年论文
@wuu
name
The role of capecitabine, an o ...... t of metastatic breast cancer.
@ast
The role of capecitabine, an o ...... t of metastatic breast cancer.
@en
type
label
The role of capecitabine, an o ...... t of metastatic breast cancer.
@ast
The role of capecitabine, an o ...... t of metastatic breast cancer.
@en
prefLabel
The role of capecitabine, an o ...... t of metastatic breast cancer.
@ast
The role of capecitabine, an o ...... t of metastatic breast cancer.
@en
P1433
P1476
The role of capecitabine, an o ...... t of metastatic breast cancer.
@en
P2093
P356
10.1634/THEONCOLOGIST.6-1-56
P577
2001-01-01T00:00:00Z